What is Softgel?
Softgel operates as a critical infrastructure provider in the nutraceutical and pharmaceutical supply chain, specializing in custom formulations, contract manufacturing, and comprehensive packaging solutions. The company distinguishes itself through a versatile production portfolio that encompasses both traditional gelatin and plant-based veggie softgels, alongside specialized tincture manufacturing. By serving as a strategic partner for brands aiming to launch or expand their product lines, Softgel ensures rigorous quality control and consistency. Their market position is defined by a service-first methodology, enabling clients to navigate the complexities of nutritional oil encapsulation with technical precision and operational efficiency.
How much funding has Softgel raised?
Softgel has raised a total of $295K across 2 funding rounds:
Debt
$150K
Debt
$145K
Debt (2020): $150K with participation from PPP
Debt (2021): $145K led by PPP
Key Investors in Softgel
PPP
Public-Private Partnership
What's next for Softgel?
With this recent infusion of capital, Softgel is well-positioned to accelerate its operational footprint and enhance its manufacturing throughput. The company's strategic roadmap likely involves upgrading its facility infrastructure to accommodate higher volume requirements and diversifying its formulation capabilities to address emerging trends in the health and wellness market. As the firm transitions through this late-stage growth phase, the focus will remain on maintaining its reputation for reliability while scaling its capacity to support global brand partners. Future initiatives will likely prioritize technological integration in the production process to further solidify its competitive advantage in the softgel innovation space.
See full Softgel company page
